PrEPVacc announces enrolment ‘almost complete’ during World AIDS Day 2022

PrEPVacc recognised World Aids Day 2022 with a handful of social media posts across its Twitter, Facebook and LinkedIn accounts, letting its followers and its communities know that it was close to reaching its enrolment target.

Enrolment in the @PrEPVacc study is almost complete across our four #HIVVaccine and #PrEP clinical trial sites in East and Southern Africa. #WorldAIDSDay #HIVPrevention #WorldAIDSDay2022 @EDCTP pic.twitter.com/nLnkOfuMyt

— PrEPVacc (@PrEPVacc) December 1, 2022

---

Thanks to the hard work and support of our participants, staff and their communities, enrolment to the @PrEPVacc #HIVvaccine and #PrEP clinical trial is almost complete. #WorldAIDSDay #HIVPrevention #WorldAIDSDay2022 pic.twitter.com/b1nxjfAbJP

— PrEPVacc (@PrEPVacc) December 1, 2022

---

African-led, European-supported – the @PrEPVacc #HIVvaccine and #PrEP clinical trial has almost reached its enrolment target.#WorldAIDSDay #HIVPrevention #WAD22 #WorldAIDSDay2022 @EDCTP pic.twitter.com/iJbtSjRvaq

— PrEPVacc (@PrEPVacc) December 1, 2022

---